Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine versus placebo in chronic heart failure with preserved ejection fraction
2012-002742-20Phase 2Completed
- Sponsor
- Servier
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) and chronic heart failure (CHF) comparing Ivabradine arm with Placebo arm (2 arms). Primary endpoints: Diastolic function (E/e'), Neuroendocrine activation (NT-proBNP) and 1 more. Started Feb 2013; status: completed.
02
Drugs
ivabradine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2012-002742-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002742-20.